Ngā hua rapu - Steven R. Alberts

Whakamahine hua
  1. 1
    Chemotherapy for Colorectal Cancer Liver Metastases

    Chemotherapy for Colorectal Cancer Liver Metastases mā Steven R. Alberts, Lawrence D. Wagman

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Gastric cancer: epidemiology, pathology and treatment

    Gastric cancer: epidemiology, pathology and treatment mā Steven R. Alberts, Andrés Cervantes, Cornelis J.�H. van de Velde

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates

    Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates mā Gunnar Folprecht, Axel Grothey, Steven R. Alberts, Hans-Rudolf Raab, C.-H. Köhne

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Clinical Predictors of Severe Cetuximab-Induced Rash: Observations from 933 Patients Enrolled in North Central Cancer Treatment Group Study N0147

    Clinical Predictors of Severe Cetuximab-Induced Rash: Observations from 933 Patients Enrolled in North Central Cancer Treatment Group Study N0147 mā Aminah Jatoi, Erin M. Green, Kendrith M. Rowland, Daniel J. Sargent, Steven R. Alberts

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer

    MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer mā Jinsei Miyoshi, Shusuke Toden, Kazuhiro Yoshida, Yuji Toiyama, Steven R. Alberts, Masato Kusunoki, Frank A. Sinicrope, Ajay Goel

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)

    Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance) mā H. Lee, Dan Sha, Nathan R. Foster, Qian Shi, Steven R. Alberts, Thomas C. Smyrk, Frank A. Sinicrope

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Racial Differences in<i>BRAF</i>/<i>KRAS</i>Mutation Rates and Survival in Stage III Colon Cancer Patients

    Racial Differences in<i>BRAF</i>/<i>KRAS</i>Mutation Rates and Survival in Stage III Colon Cancer Patients mā Harry H. Yoon, Qian Shi, Steven R. Alberts, Richard M. Goldberg, Stephen N. Thibodeau, Daniel J. Sargent, Frank A. Sinicrope

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma

    Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma mā Steven R. Alberts, Tom R. Fitch, George P. Kim, Bruce W. Morlan, Shaker R. Dakhil, Howard M. Gross, Suresh Nair

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Associations Between Cigarette Smoking Status and Colon Cancer Prognosis Among Participants in North Central Cancer Treatment Group Phase III Trial N0147

    Associations Between Cigarette Smoking Status and Colon Cancer Prognosis Among Participants in North Central Cancer Treatment Group Phase III Trial N0147 mā Amanda I. Phipps, Qian Shi, Polly A. Newcomb, Garth D. Nelson, Daniel J. Sargent, Steven R. Alberts, Paul J. Limburg

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Improving Adherence to Cancer Treatment by Addressing Quality of Life in Patients With Advanced Gastrointestinal Cancers

    Improving Adherence to Cancer Treatment by Addressing Quality of Life in Patients With Advanced Gastrointestinal Cancers mā Andrea Cheville, Steven R. Alberts, Teresa A. Rummans, Jeffrey R. Basford, Maria I. Lapid, Jeff A. Sloan, Daniel Satele, Matthew M. Clark

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Liver Transplantation with Neoadjuvant Chemoradiation is More Effective than Resection for Hilar Cholangiocarcinoma

    Liver Transplantation with Neoadjuvant Chemoradiation is More Effective than Resection for Hilar Cholangiocarcinoma mā David Rea, Julie K. Heimbach, Charles B. Rosen, Michael G. Haddock, Steven R. Alberts, Walter K. Kremers, Gregory J. Gores, David M. Nagorney

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma

    Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma mā Sarwa Darwish Murad, W. Ray Kim, Terry M. Therneau, Gregory J. Gores, Charles B. Rosen, James A. Martenson, Steven R. Alberts, Julie K. Heimbach

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

    Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncolo... mā Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol, Peter J. O’Dwyer, Edith P. Mitchell, Steven R. Alberts, Michael Schwartz, Al B. Benson

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas

    Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas mā Frank A. Sinicrope, Thomas C. Smyrk, David Tougeron, Stephen N. Thibodeau, Shalini Singh, Andrea Murányi, Kandavel Shanmugam, Thomas M. Grogan, Steven R. Alberts, Qian Shi

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    DPYD Variants as Predictors of 5-fluorouracil Toxicity in Adjuvant Colon Cancer Treatment (NCCTG N0147)

    DPYD Variants as Predictors of 5-fluorouracil Toxicity in Adjuvant Colon Cancer Treatment (NCCTG N0147) mā Adam M. Lee, Qian Shi, Emily S. Pavey, Steven R. Alberts, Daniel J. Sargent, Frank A. Sinicrope, Jeffrey L. Berenberg, Richard M. Goldberg, Robert B. Diasio

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

    A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer mā Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton, Charles S. Fuchs, Ramesh K. Ramanathan, Stephen K. Williamson, B. Findlay, Henry C. Pitot, Steven R. Alberts

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Untreated Metastatic Colorectal Cancer: A North American Intergroup Trial

    Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Un... mā Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton, Charles S. Fuchs, Ramesh K. Ramanathan, Stephen K. Williamson, B. Findlay, Henry C. Pitot, Steven R. Alberts

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Predictors of Disease Recurrence Following Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma

    Predictors of Disease Recurrence Following Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma mā Julie K. Heimbach, Gregory J. Gores, Michael G. Haddock, Steven R. Alberts, Rachel Pedersen, Walter K. Kremers, Scott L. Nyberg, Michael B. Ishitani, Charles B. Rosen

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144

    Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144 mā Grace K. Dy, Timothy J. Hobday, Garth D. Nelson, Harold E. Windschitl, Michael J. OʼConnell, Steven R. Alberts, Richard M. Goldberg, Daniel A. Nikcevich, Daniel J. Sargent

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

    Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841 mā Jan Franko, Qian Shi, Charles D. Goldman, Barbara A. Pockaj, Garth D. Nelson, Richard M. Goldberg, Henry C. Pitot, Axel Grothey, Steven R. Alberts, Daniel J. Sargent

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: